Cortechs.ai | PETQuant: Neurodegenerative Assessment in Clinical Research

PETQuant: Neurodegenerative Assessment in Clinical Research

webinar_thumbnail.pngDr. James Brewer, MD, PhD, Neurologist, UC San Diego, hosted a live webinar from our our San Diego headquarters entitled: PETQuant™: Neurodegenerative Dementia Assessment in Research. Dr. Brewer gave a fascinating and enlightening presentation about using PETQuant in clinical research and covered many topics in the video below, including:

  • Why patient native brain space is important in PET imaging
  • The value of quantifying brain structure volumes (via NeuroQuant®)
  • How PETQuant can simplify the process of interpreting PET scans
  • Several case studies

PETQuant is our recently launched for research only tool that provides brain segmentation using PET imaging studies to quantify subregional tracer binding in native brain space for FDG and Florbetapir.

If you would like more information about using PETQuant in your clinical research, please contact us.

More Resources

05/10/2025

All the Ways to Use the NeuroQuant Custom Report

With the ability to select structures from NeuroQuant’s 70+ structure parcellation atlas, the user has the power to truly personalize patient care!

05/04/2025

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Discover how the latest NeuroQuant MS update offers a clearer, more intuitive way to track lesion changes and understand disease progression over time.

05/02/2025

4 Reasons Why Over 1500 Medical Centers Worldwide Trust Cortechs.ai

Trusted by 1500+ medical centers, Cortechs.ai delivers AI-powered imaging tools that enhance diagnostic accuracy and streamline workflows.

04/22/2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Cortechs.ai receives Health Canada approval to expand its AI imaging solutions into Canada, advancing diagnostic precision and patient care.

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.
Scroll to Top